<!DOCTYPE html><html lang="en" ><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8"><meta name="theme-color" media="(prefers-color-scheme: light)" content="#f7f7f7"><meta name="theme-color" media="(prefers-color-scheme: dark)" content="#1b1b1e"><meta name="apple-mobile-web-app-capable" content="yes"><meta name="apple-mobile-web-app-status-bar-style" content="black-translucent"><meta name="viewport" content="width=device-width, user-scalable=no initial-scale=1, shrink-to-fit=no, viewport-fit=cover" ><meta name="generator" content="Jekyll v4.3.2" /><meta property="og:title" content="Comparison of the Quantitative CT Imaging Biomarkers of Idiopathic Pulmonary Fibrosis at Baseline and Early Change with an Interval of 7 Months" /><meta property="og:locale" content="en" /><meta name="description" content="Rationale and Objectives" /><meta property="og:description" content="Rationale and Objectives" /><link rel="canonical" href="https://clinicaltree.github.io/posts/comparison-of-the-quantitative-ct-imaging-biomarkers-of-idiopathic-pulmonary-fibrosis-at-baseline-an/" /><meta property="og:url" content="https://clinicaltree.github.io/posts/comparison-of-the-quantitative-ct-imaging-biomarkers-of-idiopathic-pulmonary-fibrosis-at-baseline-an/" /><meta property="og:site_name" content="Radiology Tree" /><meta property="og:type" content="article" /><meta property="article:published_time" content="2014-12-31T17:00:00+00:00" /><meta name="twitter:card" content="summary" /><meta property="twitter:title" content="Comparison of the Quantitative CT Imaging Biomarkers of Idiopathic Pulmonary Fibrosis at Baseline and Early Change with an Interval of 7 Months" /><meta name="twitter:site" content="@twitter_username" /><meta name="google-site-verification" content="RFHVRgQqK0eGjftEMCTDhsDrR8cJ_ZYcfCX52gXW8KM" /> <script type="application/ld+json"> {"@context":"https://schema.org","@type":"BlogPosting","dateModified":"2023-04-10T02:43:55+00:00","datePublished":"2014-12-31T17:00:00+00:00","description":"Rationale and Objectives","headline":"Comparison of the Quantitative CT Imaging Biomarkers of Idiopathic Pulmonary Fibrosis at Baseline and Early Change with an Interval of 7 Months","mainEntityOfPage":{"@type":"WebPage","@id":"https://clinicaltree.github.io/posts/comparison-of-the-quantitative-ct-imaging-biomarkers-of-idiopathic-pulmonary-fibrosis-at-baseline-an/"},"url":"https://clinicaltree.github.io/posts/comparison-of-the-quantitative-ct-imaging-biomarkers-of-idiopathic-pulmonary-fibrosis-at-baseline-an/"}</script><title>Comparison of the Quantitative CT Imaging Biomarkers of Idiopathic Pulmonary Fibrosis at Baseline and Early Change with an Interval of 7 Months | Radiology Tree</title><link rel="apple-touch-icon" sizes="180x180" href="/assets/img/favicons/apple-touch-icon.png"><link rel="icon" type="image/png" sizes="32x32" href="/assets/img/favicons/favicon-32x32.png"><link rel="icon" type="image/png" sizes="16x16" href="/assets/img/favicons/favicon-16x16.png"><link rel="manifest" href="/assets/img/favicons/site.webmanifest"><link rel="shortcut icon" href="/assets/img/favicons/favicon.ico"><meta name="apple-mobile-web-app-title" content="Radiology Tree"><meta name="application-name" content="Radiology Tree"><meta name="msapplication-TileColor" content="#da532c"><meta name="msapplication-config" content="/assets/img/favicons/browserconfig.xml"><meta name="theme-color" content="#ffffff"><link rel="preconnect" href="https://fonts.googleapis.com" ><link rel="dns-prefetch" href="https://fonts.googleapis.com" ><link rel="preconnect" href="https://fonts.gstatic.com" crossorigin><link rel="dns-prefetch" href="https://fonts.gstatic.com" crossorigin><link rel="preconnect" href="https://fonts.googleapis.com" ><link rel="dns-prefetch" href="https://fonts.googleapis.com" ><link rel="preconnect" href="https://cdn.jsdelivr.net" ><link rel="dns-prefetch" href="https://cdn.jsdelivr.net" ><link rel="stylesheet" href="https://fonts.googleapis.com/css2?family=Lato&family=Source+Sans+Pro:wght@400;600;700;900&display=swap"><link rel="preconnect" href="https://www.google-analytics.com" crossorigin="use-credentials"><link rel="dns-prefetch" href="https://www.google-analytics.com"><link rel="preconnect" href="https://www.googletagmanager.com" crossorigin="anonymous"><link rel="dns-prefetch" href="https://www.googletagmanager.com"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/bootstrap@4.6.2/dist/css/bootstrap.min.css"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/@fortawesome/fontawesome-free@6.2.1/css/all.min.css"><link rel="stylesheet" href="/assets/css/style.css"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/tocbot@4.20.1/dist/tocbot.min.css"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/magnific-popup@1.1.0/dist/magnific-popup.min.css"> <script src="https://cdn.jsdelivr.net/npm/jquery@3.6.1/dist/jquery.min.js"></script> <script type="text/javascript"> class ModeToggle { static get MODE_KEY() { return "mode"; } static get MODE_ATTR() { return "data-mode"; } static get DARK_MODE() { return "dark"; } static get LIGHT_MODE() { return "light"; } static get ID() { return "mode-toggle"; } constructor() { if (this.hasMode) { if (this.isDarkMode) { if (!this.isSysDarkPrefer) { this.setDark(); } } else { if (this.isSysDarkPrefer) { this.setLight(); } } } let self = this; /* always follow the system prefers */ this.sysDarkPrefers.addEventListener('change', () => { if (self.hasMode) { if (self.isDarkMode) { if (!self.isSysDarkPrefer) { self.setDark(); } } else { if (self.isSysDarkPrefer) { self.setLight(); } } self.clearMode(); } self.notify(); }); } /* constructor() */ get sysDarkPrefers() { return window.matchMedia("(prefers-color-scheme: dark)"); } get isSysDarkPrefer() { return this.sysDarkPrefers.matches; } get isDarkMode() { return this.mode === ModeToggle.DARK_MODE; } get isLightMode() { return this.mode === ModeToggle.LIGHT_MODE; } get hasMode() { return this.mode != null; } get mode() { return sessionStorage.getItem(ModeToggle.MODE_KEY); } /* get the current mode on screen */ get modeStatus() { if (this.isDarkMode || (!this.hasMode && this.isSysDarkPrefer)) { return ModeToggle.DARK_MODE; } else { return ModeToggle.LIGHT_MODE; } } setDark() { $('html').attr(ModeToggle.MODE_ATTR, ModeToggle.DARK_MODE); sessionStorage.setItem(ModeToggle.MODE_KEY, ModeToggle.DARK_MODE); } setLight() { $('html').attr(ModeToggle.MODE_ATTR, ModeToggle.LIGHT_MODE); sessionStorage.setItem(ModeToggle.MODE_KEY, ModeToggle.LIGHT_MODE); } clearMode() { $('html').removeAttr(ModeToggle.MODE_ATTR); sessionStorage.removeItem(ModeToggle.MODE_KEY); } /* Notify another plugins that the theme mode has changed */ notify() { window.postMessage({ direction: ModeToggle.ID, message: this.modeStatus }, "*"); } flipMode() { if (this.hasMode) { if (this.isSysDarkPrefer) { if (this.isLightMode) { this.clearMode(); } else { this.setLight(); } } else { if (this.isDarkMode) { this.clearMode(); } else { this.setDark(); } } } else { if (this.isSysDarkPrefer) { this.setLight(); } else { this.setDark(); } } this.notify(); } /* flipMode() */ } /* ModeToggle */ const modeToggle = new ModeToggle(); </script><body data-topbar-visible="true"><div id="sidebar" class="d-flex flex-column align-items-end"><div class="profile-wrapper text-center"><div id="avatar"> <a href="/" class="mx-auto"> <img src="https://storage.googleapis.com/clinicalpub.com/images/favicon.png" alt="avatar" onerror="this.style.display='none'"> </a></div><div class="site-title"> <a href="/">Radiology Tree</a></div><div class="site-subtitle font-italic">Update every day the best and the lastest articles, books, journals, clinical cases, videos, images... for radiologist</div></div><ul class="w-100"><li class="nav-item"> <a href="/" class="nav-link"> <i class="fa-fw fas fa-home ml-xl-3 mr-xl-3 unloaded"></i> <span>HOME</span> </a><li class="nav-item"> <a href="/categories/" class="nav-link"> <i class="fa-fw fas fa-stream ml-xl-3 mr-xl-3 unloaded"></i> <span>CATEGORIES</span> </a><li class="nav-item"> <a href="/tags/" class="nav-link"> <i class="fa-fw fas fa-tag ml-xl-3 mr-xl-3 unloaded"></i> <span>TAGS</span> </a><li class="nav-item"> <a href="/archives/" class="nav-link"> <i class="fa-fw fas fa-archive ml-xl-3 mr-xl-3 unloaded"></i> <span>ARCHIVES</span> </a><li class="nav-item"> <a href="/about/" class="nav-link"> <i class="fa-fw fas fa-info-circle ml-xl-3 mr-xl-3 unloaded"></i> <span>ABOUT</span> </a></ul><div class="sidebar-bottom mt-auto d-flex flex-wrap justify-content-center align-items-center"> <button class="mode-toggle btn" aria-label="Switch Mode"> <i class="fas fa-adjust"></i> </button> <span class="icon-border"></span> <a href="https://github.com/clinicaltree" aria-label="github" target="_blank" rel="noopener noreferrer"> <i class="fab fa-github"></i> </a> <a href="https://twitter.com/twitter_username" aria-label="twitter" target="_blank" rel="noopener noreferrer"> <i class="fab fa-twitter"></i> </a> <a href="javascript:location.href = 'mailto:' + ['clinicalpub.team','gmail.com'].join('@')" aria-label="email" > <i class="fas fa-envelope"></i> </a> <a href="/feed.xml" aria-label="rss" > <i class="fas fa-rss"></i> </a></div></div><div id="topbar-wrapper"><div id="topbar" class="container d-flex align-items-center justify-content-between h-100 pl-3 pr-3 pl-md-4 pr-md-4"> <span id="breadcrumb"> <span> <a href="/"> Home </a> </span> <span>Comparison of the Quantitative CT Imaging Biomarkers of Idiopathic Pulmonary Fibrosis at Baseline and Early Change with an Interval of 7 Months</span> </span> <i id="sidebar-trigger" class="fas fa-bars fa-fw"></i><div id="topbar-title"> Post</div><i id="search-trigger" class="fas fa-search fa-fw"></i> <span id="search-wrapper" class="align-items-center"> <i class="fas fa-search fa-fw"></i> <input class="form-control" id="search-input" type="search" aria-label="search" autocomplete="off" placeholder="Search..."> </span> <span id="search-cancel" >Cancel</span></div></div><div id="main-wrapper" class="d-flex justify-content-center"><div id="main" class="container pl-xl-4 pr-xl-4"><div class="row"><div id="core-wrapper" class="col-12 col-lg-11 col-xl-9 pr-xl-4"><div class="post pl-1 pr-1 pl-md-2 pr-md-2"><h1 data-toc-skip>Comparison of the Quantitative CT Imaging Biomarkers of Idiopathic Pulmonary Fibrosis at Baseline and Early Change with an Interval of 7 Months</h1><div class="post-meta text-muted"> <span> Posted <em class="" data-ts="1420045200" data-df="ll" data-toggle="tooltip" data-placement="bottom"> Dec 31, 2014 </em> </span> <span> Updated <em class="" data-ts="1681094635" data-df="ll" data-toggle="tooltip" data-placement="bottom"> Apr 10, 2023 </em> </span><div class="d-flex justify-content-between"> <span> By <em> <a href="">Hyun J. Kim MS PhD</a> </em>, <em> <a href="">Matthew S. Brown PhD</a> </em>, <em> <a href="">Daniel Chong MS</a> </em>, <em> <a href="">David W. Gjertson PhD</a> </em>, <em> <a href="">Peiyun Lu MS</a> </em>, <em> <a href="">Hak J. Kim MS</a> </em>, <em> <a href="">Heidi Coy BS</a> </em>, <em> <a href="">Jonathan G. Goldin MD PhD</a> </em> </span><div> <span class="readtime" data-toggle="tooltip" data-placement="bottom" title="3644 words"> <em>20 min</em> read</span></div></div></div><div class="post-content"><h2 id="rationale-and-objectives"><span class="mr-2">Rationale and Objectives</span><a href="#rationale-and-objectives" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>Median survival of patients with idiopathic pulmonary fibrosis (IPF) is 2–5 years. Sensitive imaging metrics can play a role in detecting early changes in therapeutic development. The aim of the present study was to compare known computed tomography (CT) histogram kurtosis and a classifier-based quantitative score to assess baseline severity and change over time in patients with IPF.</p><h2 id="materials-and-methods"><span class="mr-2">Materials and Methods</span><a href="#materials-and-methods" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>A total of 57 patients with at least baseline and paired follow-up scans were selected from an imaging database of standardized CT scans obtained from patients with IPF. CT histogram measurement of kurtosis and quantitative lung fibrosis (QLF) and quantitative interstitial lung disease (QILD) scores from a classification algorithm were calculated. Spearman rank correlations were used to assess associations between baseline severity and changes for all CT-derived measures compared to forced vital capacity (FVC) and carbon monoxide diffusion capacity (DL CO ) (percent predicted).</p><h2 id="results"><span class="mr-2">Results</span><a href="#results" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>At baseline, mean (±SD) of kurtosis was 2.43 (±1.83). Mean (±SD) values of QLF and QILD scores were 20.7% (±13.4) and 43.3% (±20.0), respectively. All baseline histogram indices and QLF and QILD scores were correlated well with baseline FVC and DL CO . When assessing associations with changes in FVC and DL CO over time, only QLF score was statistically significant (ρ = −0.57; <em>P</em> &lt; .0001 for FVC and ρ = −0.34; <em>P</em> = .025 for DL CO ), whereas kurtosis was not.</p><h2 id="conclusions"><span class="mr-2">Conclusions</span><a href="#conclusions" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>Classifier-model-derived scores (QLF and QILD), based on a set of texture features, are associated with baseline disease extent and are also a sensitive measure of change over time. A QLF score can be used for measuring the extent of disease severity and longitudinal changes.</p><p>Idiopathic pulmonary fibrosis (IPF) is a rare and ultimately fatal lung disease of unknown cause with a median survival of 2–5 years . Although several studies have identified risk factors and histopathologic features, the natural history of IPF is poorly understood and the rate of progression for a given patient can be unpredictable. Disease progression ranges from very rapid to remaining stable over several years and may be punctuated by acute worsening . Diagnosing IPF can also be challenging as distinct from other diffuse lung diseases . High-resolution computed tomography (HRCT) plays an indispensable role in the diagnosis of IPF. Predicating the presence of a classically subpleural, basilar distribution of interstitial abnormalities, or other known causes of interstitial lung disease, the HRCT features obviate the need for surgical biopsy . Evidence of classic visual feature of IPF on thoracic CT is often used as inclusion criteria in clinical trials. Guidelines have been developed for assigning a confidence to a diagnosis of IPF on CT . There are currently very limited treatment options for patients diagnosed with IPF. Important to the success of IPF clinical trials are the inclusion of correctly characterized patients and the demonstration of clinically meaningful benefits .</p><p>Development of a sensitive surrogate measure for IPF has become increasingly urgent, as the understanding of underlying pathophysiology of IPF has led to several potential, new antifibrotic therapies . In measuring treatment outcomes, a change in forced vital capacity (FVC) has been most often used. The progression is normally defined as 10% drop in FVC. The implication of progression in FVC differs in patients with moderate and severe IPF. Other outcomes have included the 6-minute walk test, carbon monoxide diffusion capacity (DL CO ), and quality of life instruments . More recently the Food and Drug Administration suggested that mortality as an ideal endpoint be used in pivotal clinical trials . The usage of survival requires large study populations and long trials making this economically and logistically challenging. Overall survival as an outcome need to consider systematic biases at clinical centers, socioeconomic status, and censoring because of lung transplant if a patient is eligible . Development and evaluation of the HRCT method, whose measurement is sensitive to the early localized changes, is important to assess or confirm the effect of therapy on patients with IPF.</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="materials-and-methods-1"><span class="mr-2">Materials and methods</span><a href="#materials-and-methods-1" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><h2 id="patient-selection"><span class="mr-2">Patient Selection</span><a href="#patient-selection" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="ct-scanning-protocol"><span class="mr-2">CT Scanning Protocol</span><a href="#ct-scanning-protocol" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="quantitative-ct-image-analysis"><span class="mr-2">Quantitative CT Image Analysis</span><a href="#quantitative-ct-image-analysis" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="ct-histogram-features"><span class="mr-2">CT Histogram Features</span><a href="#ct-histogram-features" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p>Kurtosis=(x−x¯)4[∑(x−x¯)2]2−3, Kurtosis</p><p>=</p><p>(</p><p>x</p><p>−</p><p>x</p><p>¯</p><p>)</p><p>4</p><p>[</p><p>∑</p><p>(</p><p>x</p><p>−</p><p>x</p><p>¯</p><p>)</p><p>2</p><p>]</p><p>2</p><p>−</p><p>3</p><p>,</p><p>where <em>x</em> indicates CT density ranging from −1024 to +200 HU and x¯ x</p><p>¯ is the mean Hounsfield unit value from the CT attenuation histogram.</p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/ComparisonoftheQuantitativeCTImagingBiomarkersofIdiopathicPulmonaryFibrosisatBaselineandEarlyChangewithanIntervalof7Months/0_1s20S1076633214003110.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/ComparisonoftheQuantitativeCTImagingBiomarkersofIdiopathicPulmonaryFibrosisatBaselineandEarlyChangewithanIntervalof7Months/0_1s20S1076633214003110.jpg" alt="Figure 1, Two patients with mild and severe IPF (FVC 65%, and 47%, respectively): kurtosis measures are 5.00 and 0.41 in subjects with mild and severe IPF, respectively. Corresponding skewness measures are 1.48 and 0.80. FVC, forced vital capacity; IPF, idiopathic pulmonary fibrosis." class="lazyload" data-proofer-ignore></a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="quantitative-ct-scores-from-texture-classification-model"><span class="mr-2">Quantitative CT Scores from Texture Classification Model</span><a href="#quantitative-ct-scores-from-texture-classification-model" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p>QLFscore(%)=voxelsclassifiedasreticularpatternstotalsamples×100, QLF</p><p>score</p><p>(</p><p>%</p><p>)</p><p>=</p><p>v</p><p>o</p><p>x</p><p>e</p><p>l</p><p>s</p><p>c</p><p>l</p><p>a</p><p>s</p><p>s</p><p>i</p><p>f</p><p>i</p><p>e</p><p>d</p><p>a</p><p>s</p><p>r</p><p>e</p><p>t</p><p>i</p><p>c</p><p>u</p><p>l</p><p>a</p><p>r</p><p>p</p><p>a</p><p>t</p><p>t</p><p>e</p><p>r</p><p>n</p><p>s</p><p>t</p><p>o</p><p>t</p><p>a</p><p>l</p><p>s</p><p>a</p><p>m</p><p>p</p><p>l</p><p>e</p><p>s</p><p>×</p><p>100</p><p>,</p><p>QLFvolume(L)=(QLFscore/100)×segmentedlungorlobarvolume(L), QLF</p><p>volume</p><p>(</p><p>L</p><p>)</p><p>=</p><p>(</p><p>Q</p><p>L</p><p>F</p><p>s</p><p>c</p><p>o</p><p>r</p><p>e</p><p>/</p><p>100</p><p>)</p><p>×</p><p>s</p><p>e</p><p>g</p><p>m</p><p>e</p><p>n</p><p>t</p><p>e</p><p>d</p><p>l</p><p>u</p><p>n</p><p>g</p><p>o</p><p>r</p><p>l</p><p>o</p><p>b</p><p>a</p><p>r</p><p>v</p><p>o</p><p>l</p><p>u</p><p>m</p><p>e</p><p>(</p><p>L</p><p>)</p><p>,</p><p>QILDscore(%)=voxelsclassifiedasabnomalpatternstotalsamples×100, QILD</p><p>score</p><p>(</p><p>%</p><p>)</p><p>=</p><p>v</p><p>o</p><p>x</p><p>e</p><p>l</p><p>s</p><p>c</p><p>l</p><p>a</p><p>s</p><p>s</p><p>i</p><p>f</p><p>i</p><p>e</p><p>d</p><p>a</p><p>s</p><p>a</p><p>b</p><p>n</p><p>o</p><p>m</p><p>a</p><p>l</p><p>p</p><p>a</p><p>t</p><p>t</p><p>e</p><p>r</p><p>n</p><p>s</p><p>t</p><p>o</p><p>t</p><p>a</p><p>l</p><p>s</p><p>a</p><p>m</p><p>p</p><p>l</p><p>e</p><p>s</p><p>×</p><p>100</p><p>,</p><p>QILDvolume(L)=(QILDscore/100)×segmentedlungorlobarvolume(L). QILD</p><p>volume</p><p>(</p><p>L</p><p>)</p><p>=</p><p>(</p><p>Q</p><p>I</p><p>L</p><p>D</p><p>s</p><p>c</p><p>o</p><p>r</p><p>e</p><p>/</p><p>100</p><p>)</p><p>×</p><p>s</p><p>e</p><p>g</p><p>m</p><p>e</p><p>n</p><p>t</p><p>e</p><p>d</p><p>l</p><p>u</p><p>n</p><p>g</p><p>o</p><p>r</p><p>l</p><p>o</p><p>b</p><p>a</p><p>r</p><p>v</p><p>o</p><p>l</p><p>u</p><p>m</p><p>e</p><p>(</p><p>L</p><p>)</p><p>.</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="statistical-analysis"><span class="mr-2">Statistical Analysis</span><a href="#statistical-analysis" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="results-1"><span class="mr-2">Results</span><a href="#results-1" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><h2 id="descriptive-summary-statistics"><span class="mr-2">Descriptive Summary Statistics</span><a href="#descriptive-summary-statistics" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p>Table 1</p><p>Characteristics of Idiopathic Pulmonary Fibrosis Subjects</p><p>Variables Baseline ( <em>N</em> = 57) Follow-Up ( <em>N</em> = 57)<em>P</em> value Mean (SD) Median (IQR) Mean (SD) Median (IQR) Pulmonary function tests TLC volume ∗ (L) 4.11 (0.96) 4.13 (0.87) 3.93 (1.01) 4.04 (1.42) .2190 RV volume ∗ (L) 1.50 (0.69) 1.44 (0.81) 1.36 (0.52) 1.31 (0.81) .9523 FVC (% pred) 65.18 (12.44) 66.40 (18.80) 62.79 (14.05) 63.60 (18.40) .0001 † FEV 1 (% pred) 71.34 (13.03) 72.60 (18.30) 68.28 (14.82) 69.00 (20.70) &lt;.0001 DL CO ∗ (% pred) 49.67 (14.19) 47.00 (15.70) 45.18 (13.53) 44.50 (17.50) &lt;.0001 CT histogram indexes Kurtosis 2.81 (1.83) 2.38 (2.44) 2.26 (1.77) 1.83 (1.93) &lt;.0001 † Mean −768.28 (53.62) −772.87 (63.88) −756.40 (62.82) −757.91 (79.06) .0329 † Variance 44,299.30 (15,065.58) 42,578.12 (21,196.77) 44,299.30 (15,065.58) 42,578.12 (21,196.77) .1626 Skewness 1.58 (0.42) 1.59 (0.53) 1.47 (0.43) 1.46 (0.53) &lt;.0001 Entropy 6.37 (0.24) 6.33 (0.29) 6.39 (0.27) 6.36 (0.31) .1741 Median −829.32 (50.63) −832.00 (62.00) −819.67 (56.90) −817.00 (58.00) .0811 Quantitative CT texture scores QLF score (%) 17.63 (10.10) 17.00 (13.00) 20.37 (11.99) 18.00 (14.00) &lt;.0001 † Ground glass score (%) 17.53 (7.44) 16.00 (11.00) 17.25 (7.30) 17.00 (10.00) .6435 QILD score (%) 39.02 (17.22) 38.00 (21.00) 41.33 (17.86) 39.00 (23.00) .0453 QLF volume (L) 0.63 (0.39) 0.56 (0.31) 0.71 (0.41) 0.64 (0.35) .0002 Ground glass volume (L) 0.63 (0.23) 0.61 (0.35) 0.61 (0.25) 0.61 (0.33) .6590 QILD volume (L) 1.39 (0.63) 1.30 (0.55) 1.46 (0.65) 1.31 (0.64) .0521 †</p><p>CT, computed tomography; TLC, total lung capacity; RV, residual volume. DL CO , carbon monoxide diffusion capacity; FEV, forced expiratory volume in 1 second; FVC, forced vital capacity; IQR, interquartile range; QLF, quantitative lung fibrosis; QILD, quantitative interstitial lung disease; SD, standard deviation.</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/ComparisonoftheQuantitativeCTImagingBiomarkersofIdiopathicPulmonaryFibrosisatBaselineandEarlyChangewithanIntervalof7Months/1_1s20S1076633214003110.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/ComparisonoftheQuantitativeCTImagingBiomarkersofIdiopathicPulmonaryFibrosisatBaselineandEarlyChangewithanIntervalof7Months/1_1s20S1076633214003110.jpg" alt="Figure 2, (a) Baseline CT scan: FVC is 54.4% and CT TLC volume is 3.51 L; (b) follow-up CT scan: FVC is 53.5%, DL CO decreased by 8.6%, and CT volume is 3.34 L; (c) baseline classification overlay for QLF score at whole lung of 15% in blue and red and QILD of 43% (not overlaid); (d) follow-up classification overlay for QLF score of 22% in blue and red and QILD of 52% (not overlaid); (e) baseline histogram with kurtosis of 2.24; (f) follow-up kurtosis of 2.51, which is greater than baseline (indicating improvement which is not consistent with FVC and QLF). CT, computed tomography; DL CO , carbon monoxide diffusion capacity; FVC, forced vital capacity; QILD, quantitative interstitial lung disease; QLF, quantitative lung fibrosis. For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article." class="lazyload" data-proofer-ignore></a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="associations"><span class="mr-2">Associations</span><a href="#associations" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><h2 id="whole-lung"><span class="mr-2">Whole Lung</span><a href="#whole-lung" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p>Table 2</p><p>Association at Baseline at Whole Lung</p><p>Baseline Percent Predicted FVC (%), <em>N</em> = 57 Percent Predicted FEV 1 (%), <em>N</em> = 57 Percent Predicted DL CO (%), <em>N</em> = 51 CT histogram indexes Kurtosis 0.56 ( <em>P</em> &lt; .0001) 0.49 ( <em>P</em> = .0001) 0.44 ( <em>P</em> = .0014) Mean −0.60 ( <em>P &lt; .0001</em> ) −0.45 ( <em>P</em> = .0005) −0.36 ( <em>P</em> = .0094) Variance −0.55 ( <em>P</em> &lt; .0001) −0.56 ( <em>P</em> &lt; .0001) −0.31 ( <em>P</em> = .0264) Skewness 0.50 ( <em>P</em> &lt; .0001) 0.43 ( <em>P</em> = .0007) 0.07 ( <em>P</em> = .003) Entropy −0.54 ( <em>P</em> &lt; .0001) −0.51 ( <em>P</em> &lt; .0001) −0.44 ( <em>P</em> = .0013) Median −0.22 ( <em>P</em> = .107) −0.17 ( <em>P</em> = .197) −0.2544 ( <em>P</em> = .072) Quantitative CT texture scores QLF score (%) −0.59 ( <em>P</em> &lt; .0001) −0.51 ( <em>P</em> &lt; .0001) −0.46 ( <em>P</em> = .0007) Ground glass (%) −0.36 ( <em>P</em> = .0053) −0.20 ( <em>P</em> = .1270) −0.28 ( <em>P</em> = .0431) QILD score (%) −0.58 ( <em>P</em> &lt; .0001) −0.50 ( <em>P</em> = .0001) −0.45 ( <em>P</em> = .0009) QLF volume (L) −0.44 ( <em>P</em> = .0006) − <em>0.38 (P = .0033)</em> −0.35 ( <em>P</em> = .0123) Ground glass (L) −0.04 ( <em>P</em> = .75) 0.059 ( <em>P</em> = .66) 0.04 ( <em>P</em> = .78) QILD volume (L) −0.30 ( <em>P</em> = .021) −0.25 ( <em>P</em> = .064) −0.22 ( <em>P</em> = .117)</p><p>CT, computed tomography; DL CO , carbon monoxide diffusion capacity; FEV, forced expiratory volume in 1 second; FVC, forced vital capacity; QLF, quantitative lung fibrosis; QILD, quantitative interstitial lung disease.</p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/ComparisonoftheQuantitativeCTImagingBiomarkersofIdiopathicPulmonaryFibrosisatBaselineandEarlyChangewithanIntervalof7Months/2_1s20S1076633214003110.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/ComparisonoftheQuantitativeCTImagingBiomarkersofIdiopathicPulmonaryFibrosisatBaselineandEarlyChangewithanIntervalof7Months/2_1s20S1076633214003110.jpg" alt="Figure 3, Association with PFT of kurtosis and QLF at baseline for whole lung. DL CO , carbon monoxide diffusion capacity; FEV, forced expiratory volume in 1 second; FVC, forced vital capacity; QLF, quantitative lung fibrosis." class="lazyload" data-proofer-ignore></a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p>Table 3</p><p>Association in the Change Assessment for Whole Lung</p><p>Changes Percent Predicted FVC (%), <em>N</em> = 57, ρ ( <em>P</em> value) Percent Predicted FEV 1 (%), <em>N</em> = 57, ρ ( <em>P</em> value) DL CO (%), <em>N</em> = 43, ρ ( <em>P</em> value) CT histogram indexes Kurtosis 0.26 ( <em>P</em> = .0513) 0.0719 ( <em>P</em> = .60) −0.1626 ( <em>P</em> = .30) Mean −0.54 ( <em>P</em> &lt; .0001) −0.4442 ( <em>P</em> = .0005) −0.2384 ( <em>P</em> = .12) Variance −0.22 ( <em>P</em> = .1061) −0.2077 ( <em>P</em> = .1211) −0.2505 ( <em>P</em> = .11) Skewness 0.41 ( <em>P</em> = .0017) 0.2116 ( <em>P</em> = .1140) 0.0414 ( <em>P</em> = .79) Entropy −0.36 ( <em>P</em> = .0055) −0.3195 ( <em>P</em> = .0154) −0.2605 ( <em>P</em> = .0916) Median −0.52 ( <em>P</em> &lt; .0001) −0.4099 ( <em>P</em> = .0015) −0.2459 ( <em>P</em> = .11) Quantitative CT texture scores QLF score (%)<em>−0.57 (P &lt; .0001)</em> −0.49 ( <em>P</em> = .0001) −0.34 ( <em>P</em> = .0251) Ground glass (%) −0.31 ( <em>P</em> = .0185) −0.26 ( <em>P</em> = .0512) −0.034 ( <em>P</em> = .83) QILD score (%) −0.45 ( <em>P</em> = .0004) −0.39 ( <em>P</em> = .0030) −0.21 ( <em>P</em> = .17) QLF volume (L)<em>−0.51</em> ( <em>P</em> &lt; .0001) −0.44 ( <em>P</em> = .0005) −0.37 ( <em>P</em> = .0149) Ground glass (L) −0.19 ( <em>P</em> = .15) −0.14 ( <em>P</em> = .32) 0.018 ( <em>P</em> = .91) QILD volume (L) −0.38 ( <em>P</em> = .0033) −0.34 ( <em>P</em> = .0103) −0.27 ( <em>P</em> = .0753)</p><p>CT, computed tomography; DL CO , carbon monoxide diffusion capacity; FEV, forced expiratory volume in 1 second; FVC, forced vital capacity; QLF, quantitative lung fibrosis; QILD, quantitative interstitial lung disease.</p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/ComparisonoftheQuantitativeCTImagingBiomarkersofIdiopathicPulmonaryFibrosisatBaselineandEarlyChangewithanIntervalof7Months/3_1s20S1076633214003110.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/ComparisonoftheQuantitativeCTImagingBiomarkersofIdiopathicPulmonaryFibrosisatBaselineandEarlyChangewithanIntervalof7Months/3_1s20S1076633214003110.jpg" alt="Figure 4, Association with changes in PFT of kurtosis and QLF for whole lung. DL CO , carbon monoxide diffusion capacity; FEV, forced expiratory volume in 1 second; FVC, forced vital capacity; QLF, quantitative lung fibrosis." class="lazyload" data-proofer-ignore></a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="lobes"><span class="mr-2">Lobes</span><a href="#lobes" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p>Table 4</p><p>Association in Each Lobe and Lung</p><p>Parenchymal Regions Baseline ( <em>N</em> = 57) Changes ( <em>N</em> = 57) QLF Score vs. Percent Predicted FVC (%), ρ ( <em>P</em> value) Kurtosis vs. Percent Predicted FVC (%), ρ ( <em>P</em> value) Skewness vs. Percent Predicted FVC (%), ρ ( <em>P</em> value) QLF Score vs. Percent Predicted FVC (%), ρ ( <em>P</em> value) Kurtosis vs. Percent Predicted FVC (%), ρ ( <em>P</em> value) Skewness vs. Percent Predicted FVC (%), ρ ( <em>P</em> value) Right upper lobe −0.48 ( <em>P</em> = .0002) 0.41 ( <em>P</em> = .0015) 0.37 ( <em>P</em> = .0041) −0.53 ( <em>P</em> &lt; .0001) 0.36 ( <em>P</em> = .0062) 0.37 ( <em>P</em> = .0045) Right middle lobe −0.52 ( <em>P</em> &lt; .0001) 0.49 ( <em>P</em> = .0001) 0.46 ( <em>P</em> = .0003) −0.40 ( <em>P</em> = .0023) 0.21 ( <em>P</em> = .12) 0.22 ( <em>P</em> = .0993) Right lower lobe −0.41 ( <em>P</em> = .0013) 0.44 ( <em>P</em> = .0005) 0.39 ( <em>P</em> = .0027) −0.54 ( <em>P</em> &lt; .0001) 0.19 ( <em>P</em> = .17) 0.34 ( <em>P</em> = .0108) Left upper lobe −0.60 ( <em>P</em> &lt; .0001) 0.53 ( <em>P</em> &lt; .0001) 0.48 ( <em>P</em> = .0001) −0.56 ( <em>P</em> &lt; .0001) 0.26 ( <em>P</em> = .0479) 0.38 ( <em>P</em> = .0036) Left lower lobe −0.55 ( <em>P</em> &lt; .0001) 0.55 ( <em>P</em> &lt; .0001) 0.49 ( <em>P</em> = .0001) −0.53 ( <em>P</em> &lt; .001) 0.34 ( <em>P</em> = .0089) 0.48 ( <em>P</em> = .0002) Right lung −0.54 ( <em>P</em> &lt; .0001) 0.52 ( <em>P</em> &lt; .0001) 0.47 ( <em>P</em> = .0002) −0.55 ( <em>P</em> &lt; .0001) 0.23 ( <em>P</em> = .0908) 0.34 ( <em>P</em> = .0095) Left lung −0.60 ( <em>P</em> &lt; .0001) 0.54 ( <em>P</em> &lt; .0001) 0.48 ( <em>P</em> = .0001) −0.54 ( <em>P</em> &lt; .0001) 0.29 ( <em>P</em> = .0275) 0.44 ( <em>P</em> = .0006)</p><p>FVC, forced vital capacity; QLF, quantitative lung fibrosis.</p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/ComparisonoftheQuantitativeCTImagingBiomarkersofIdiopathicPulmonaryFibrosisatBaselineandEarlyChangewithanIntervalof7Months/4_1s20S1076633214003110.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/ComparisonoftheQuantitativeCTImagingBiomarkersofIdiopathicPulmonaryFibrosisatBaselineandEarlyChangewithanIntervalof7Months/4_1s20S1076633214003110.jpg" alt="Figure 5, (a) Association with FVC of kurtosis at baseline for each lobe and lung. (b) Association with FVC of QLF at baseline for each lobe and lung. FVC, forced vital capacity; RUL, right upper lobe; RML, right middle lobe; RLL, right lower lobe; LUL, left upper lobe; LLL, left lower lobe." class="lazyload" data-proofer-ignore></a></p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/ComparisonoftheQuantitativeCTImagingBiomarkersofIdiopathicPulmonaryFibrosisatBaselineandEarlyChangewithanIntervalof7Months/5_1s20S1076633214003110.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/ComparisonoftheQuantitativeCTImagingBiomarkersofIdiopathicPulmonaryFibrosisatBaselineandEarlyChangewithanIntervalof7Months/5_1s20S1076633214003110.jpg" alt="Figure 6, (a) Association with changes in FVC of kurtosis for each lobe and lung. (b) Association with changes in FVC of QLF for each lobe and lung. FVC, forced vital capacity; LLL, left lower lobe; LUL, left upper lobe; QLF, quantitative lung fibrosis; RLL, right lower lobe; RML, right middle lobe; RUL, right upper lobe." class="lazyload" data-proofer-ignore></a></p><p>Table 5</p><p>Association in Each Lobe and Lung</p><p>Parenchymal Regions Baseline ( <em>N</em> = 51) Changes ( <em>N</em> = 43) QLF Score vs. Percent Predicted DL CO (%), ρ ( <em>P</em> value) Kurtosis vs. Percent Predicted DL CO (%), ρ ( <em>P</em> value) Skewness vs. Percent Predicted DL CO (%), ρ ( <em>P</em> value) QLF Score vs. Percent Predicted DL CO (%), ρ ( <em>P</em> value) Kurtosis vs. Percent Predicted DL CO (%), ρ ( <em>P</em> value) Skewness vs. Percent Predicted DL CO (%), ρ ( <em>P</em> value) Right upper lobe −0.37 ( <em>P</em> = .0078) 0.36 ( <em>P</em> = .0097) 0.30 ( <em>P</em> = .0302) −0.31 ( <em>P</em> = .0462) 0.04 ( <em>P</em> = .80) 0.074 ( <em>P</em> = .64) Right middle lobe −0.39 ( <em>P</em> = .0049) 0.35 ( <em>P</em> = .0116) 0.30 ( <em>P</em> = .0331) −0.17 ( <em>P</em> = .27) −0.13 ( <em>P</em> = .41) −0.10 ( <em>P</em> = .50) Right lower lobe −0.38 ( <em>P</em> = .0057) 0.43 ( <em>P</em> = .0019) 0.35 ( <em>P</em> = .0117) −0.24 ( <em>P</em> = .12) −0.15 ( <em>P</em> = .33) −0.034 ( <em>P</em> = .83) Left upper lobe −0.43 ( <em>P</em> = .0016) 0.39 ( <em>P</em> = .0050) 0.32 ( <em>P</em> = .0200) −0.30 ( <em>P</em> = .0537) 0.004 ( <em>P</em> = .98) 0.17 ( <em>P</em> = .27) Left lower lobe −0.49 ( <em>P</em> = .0002) 0.45 ( <em>P</em> = .0008) 0.39 ( <em>P</em> = .0044) −0.33 ( <em>P</em> = .0294) −0.0168 ( <em>P</em> = .92) 0.19 ( <em>P</em> = .22) Right lung −0.43 ( <em>P</em> = .0016) 0.42 ( <em>P</em> = .0022) 0.38 ( <em>P</em> = .0055) −0.27 ( <em>P</em> = .079) 0.20 ( <em>P</em> = .21) −0.0439 ( <em>P</em> = .78) Left lung −0.48 ( <em>P</em> = .0004) 0.43 ( <em>P</em> = .0016) 0.38 ( <em>P</em> = .0056) −0.32 ( <em>P</em> = .034) −0.078 ( <em>P</em> = .62) 0.25 ( <em>P</em> = .11)</p><p>DL CO , carbon monoxide diffusion capacity; QLF, quantitative lung fibrosis.</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="discussion"><span class="mr-2">Discussion</span><a href="#discussion" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="references"><span class="mr-2">References</span><a href="#references" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><ul><li><p>1. Schwartz D.A., Helmers R.A., Galvin J.R., et. al.: Determinants of survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1994; 149: pp. 450-454.</p><li><p>2. Raghu G., Weycker D., Edelsberg J., et. al.: Incidence and prevalence of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2006; 74: pp. 810-816.</p><li><p>3. Olson A.L., Swigris J.: Idiopathic pulmonary fibrosis: diagnosis and epidemiology. Clin Chest Med 2012; 33: pp. 41-50.</p><li><p>4. GarcÃa-Sancho C., BuendÃa-RoldÃn I., FernÃndez-Plata M.R., et. al.: Familial pulmonary fibrosis is the strongest risk factor for idiopathic pulmonary fibrosis. Respir Med 2001; 105: pp. 1902-1907.</p><li><p>5. King T.E., Schwarz M.I., Brown K., et. al.: Idiopathic pulmonary fibrosis: relationship between histopathologic features and mortality. Am J Respir Crit Care Med 2001; 164: pp. 1025-1032.</p><li><p>6. Ley B., Ryerson C.J., Vittinghoff E., et. al.: A multidimensional index and staging system for idiopathic pulmonary fibrosis. Ann Intern Med 2012; 156: pp. 684-691.</p><li><p>7. du Bois R.M., Weycker D., Albera C., et. al.: Ascertainment of individual risk of mortality for patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2011; 184: pp. 459-466.</p><li><p>8. Wells A.U., Desai S.R., Rubens M.B., et. al.: Idiopathic pulmonary fibrosis: a composite physiologic index derived from disease extent observed by computed tomography. Am J Respir Crit Care Med 2003; 167: pp. 962-969.</p><li><p>9. Latsi P.I., du Bois R.M., Nicholson A.G., et. al.: Fibrotic idiopathic interstitial pneumonia: the prognostic value of longitudinal functional trends. Am J Respir Crit Care Med 2003; 168: pp. 531-537.</p><li><p>10. Raghu G., Collard H.R., Egan J., et. al.: An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 2011; 183: pp. 788-824.</p><li><p>11. Hodnett P.A., Naidich D.P.: Fibrosing interstitial lung disease. A practical high-resolution computed tomography-based approach to diagnosis and management and a review of the literature. Am J Respir Crit Care Med 2013; 188: pp. 141-149.</p><li><p>12. Raghu G., Collard H.R., Anstrom K.J., et. al.: Idiopathic pulmonary fibrosis: clinically meaningful primary endpoints in phase 3 clinical trials. Am J Respir Crit Care Med 2012; 185: pp. 1044-1048.</p><li><p>13. Cottin V.: Interstitial lung disease. Eur Respir Rev 2013; 22: pp. 26-32.</p><li><p>14. Woodcock H.V., Molyneaux P.L., Maher T.M.: Reducing lung function decline in patients with idiopathic pulmonary fibrosis: potential of nintedanib. Drug Des Devel Ther 2013; 7: pp. 503-510.</p><li><p>15. Adamali H.I., Maher T.M.: Current and novel drug therapies for idiopathic pulmonary fibrosis. Drug Des Devel Ther 2012; 6: pp. 261-272.</p><li><p>16. Loomis-King H., Flaherty K.R., Moore B.B.: Pathogenesis, current treatment and future direction for idiopathic pulmonary fibrosis. Curr Opin Pharmacol 2013; 13: pp. 377-385.</p><li><p>17. O’Connell O.J., Kennedy M.P., Henry M.T.: Idiopathic pulmonary fibrosis: treatment update. Adv Ther 2011; 28: pp. 986-999.</p><li><p>18. Mahendran S., Sethi T.: Treatments in idiopathic pulmonary fibrosis: time for a more targeted approach?. QJM 2012; 105: pp. 929-934.</p><li><p>19. Maher T.M.: PROFILEing idiopathic pulmonary fibrosis: rethinking biomarker discovery. Eur Respir Rev 2013; 22: pp. 148-152.</p><li><p>20. US Food and Drug Administration (FDA): Title of Advisory Committee document.2010.FDAMaryland Available at: http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Pulmonary-AllergyDrugsAdvisoryCommittee/UCM203081.pdf Accessed April 18, 2014</p><li><p>21. Kotloff R.M., Thabut G.: Lung Transplantation. Am J Respir Crit Care Med 2011; 184: pp. 159-171.</p><li><p>22. Best A.C., Lynch A.M., Bozic C.M., et. al.: Quantitative CT indexes in idiopathic pulmonary fibrosis: relationship with physiologic impairment. Radiology 2003; 228: pp. 407-414.</p><li><p>23. Lynch D.A.: Quantitative CT of fibrotic interstitial lung disease. Chest 2007; 131: pp. 643-644.</p><li><p>24. Camiciottoli G., Orlandi I., Bartolucci M., et. al.: Lung CT densitometry in systemic sclerosis: correlation with lung function, exercise testing, and quality of life. Chest 2007; 131: pp. 672-681.</p><li><p>25. Best A.C., Meng J., Lynch A.M., et. al.: Idiopathic pulmonary fibrosis: physiologic tests, quantitative CT indexes, and CT visual scores as predictors of mortality. Radiology 2008; 246: pp. 935-940.</p><li><p>26. Uppaluri R., Hoffman E.A., Sonka M., et. al.: Computer recognition of regional lung disease patterns. Am J Respir Crit Care Med 1999; 160: pp. 648-654.</p><li><p>27. Chabat F., Yang G.Z., Hansell D.M.: Obstructive lung diseases: texture classification for differentiation at CT. Radiology 2003; 228: pp. 871-877.</p><li><p>28. Zavaletta V.A., Bartholmai B.J., Robb R.A.: High resolution multidetector CT-aided tissue analysis and quantification of lung fibrosis. Acad Radiol 2007; 14: pp. 772-787.</p><li><p>29. Kim H.G., Tashkin D.P., Clements P.J., et. al.: A computer-aided diagnosis system for quantitative scoring of extent of lung fibrosis in scleroderma patients. Clin Exp Rheumatol 2010; 28: pp. S26-S35.</p><li><p>30. Kim H.J., Li G., Gjertson D., et. al.: Classification of parenchymal abnormality in scleroderma lung using a novel approach to denoise images collected via a multicenter study. Acad Radiol 2008; 15: pp. 1004-1016.</p><li><p>31. Maldonado F., Moua T., Rajagopalan S., et. al.: Automated quantification of radiologic patterns predicts survival in idiopathic pulmonary fibrosis. Eur Respir J 2013; 43: pp. 204-212.</p><li><p>32. Bartholmai B.J., Raghunath S., Karwoski R.A., et. al.: Quantitative computed tomography imaging of interstitial lung diseases. J Thorac Imaging 2013; 28: pp. 298-307.</p><li><p>33. Kim H.J., Brown M.S., Elashoff R., et. al.: Quantitative texture-based assessment of one-year changes in fibrotic reticular patterns on HRCT in scleroderma lung disease treated with oral cyclophosphamide. Eur Radiol 2011; 21: pp. 2455-2465.</p><li><p>34. Brown M.S., Kim H.J., Abtin F., et. al.: Reproducibility of lung and lobar volume measurements using computed tomography. Acad Radiol 2010; 17: pp. 316-322.</p><li><p>35. Cramer D.: Fundamental statistics for social research.1st ed.1997.RoutledgeNew York NYpp. 89-90.</p><li><p>36. Biomarkers Definitions Working Group: Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther 2001; 69: pp. 89-95.</p><li><p>37. Temple R.J.: A regulatory authority’s opinion about surrogate endpoints.Nimmo W.S.Tucker G.T.Clinical measurement in drug evaluation.1995.John WileyNew York:pp. 1-22.</p><li><p>38. Fan J., Li J.: Variable selection via nonconcave penalized likelihood and its oracle properties. J Am Stat Assoc 2001; 96: pp. 1348-1360.</p><li><p>39. Vapnik V.N.: The nature of statistical learning theory.2nd ed.1999.SpringerNew York, NYpp. 138-160.</p><li><p>40. Gay S.E., Kazerooni E.A., Toews G.B., et. al.: Idiopathic pulmonary fibrosis: predicting response to therapy and survival. Am J Respir Crit Care Med 1998; 157: pp. 1063-1072.</p><li><p>41. Tashkin D.P., Elashoff R., Clements P.J., et. al.: Cyclophosphamide versus placebo in scleroderma lung disease. N Engl J Med 2006; 354: pp. 2655-2666.</p><li><p>42. du Bois R.M., Weycker D., Albera C., et. al.: Forced vital capacity in patients with idiopathic pulmonary fibrosis: test properties and minimal clinically important difference. Am J Respir Crit Care Med 2011; 184: pp. 1382-1389.</p><li><p>43. Wells A.U.: Forced vital capacity as a primary end point in idiopathic pulmonary fibrosis treatment trials: making a silk purse from a sow’s ear. Thorax 2013; 68: pp. 309-310.</p></ul></div><div class="post-tail-wrapper text-muted"><div class="post-meta mb-3"> <i class="far fa-folder-open fa-fw mr-1"></i> <a href='/categories/academic-radiology/'>Academic Radiology</a>, <a href='/categories/volume-22/'>Volume 22</a>, <a href='/categories/issue-1/'>Issue 1</a></div><div class="post-tags"> <i class="fa fa-tags fa-fw mr-1"></i> <a href="/tags/journals/" class="post-tag no-text-decoration" >Journals</a> <a href="/tags/general-radiology/" class="post-tag no-text-decoration" >General Radiology</a></div><div class="post-tail-bottom d-flex justify-content-between align-items-center mt-3 pt-5 pb-2"><div class="license-wrapper"> This post is licensed under <a href="https://creativecommons.org/licenses/by/4.0/"> CC BY 4.0 </a> by the author.</div><div class="share-wrapper"> <span class="share-label text-muted mr-1">Share</span> <span class="share-icons"> <a href="https://twitter.com/intent/tweet?text=Comparison%20of%20the%20Quantitative%20CT%20Imaging%20Biomarkers%20of%20Idiopathic%20Pulmonary%20Fibrosis%20at%20Baseline%20and%20Early%20Change%20with%20an%20Interval%20of%207%20Months%20-%20Radiology%20Tree&url=https%3A%2F%2Fclinicaltree.github.io%2Fposts%2Fcomparison-of-the-quantitative-ct-imaging-biomarkers-of-idiopathic-pulmonary-fibrosis-at-baseline-an%2F" data-toggle="tooltip" data-placement="top" title="Twitter" target="_blank" rel="noopener" aria-label="Twitter"> <i class="fa-fw fab fa-twitter"></i> </a> <a href="https://www.facebook.com/sharer/sharer.php?title=Comparison%20of%20the%20Quantitative%20CT%20Imaging%20Biomarkers%20of%20Idiopathic%20Pulmonary%20Fibrosis%20at%20Baseline%20and%20Early%20Change%20with%20an%20Interval%20of%207%20Months%20-%20Radiology%20Tree&u=https%3A%2F%2Fclinicaltree.github.io%2Fposts%2Fcomparison-of-the-quantitative-ct-imaging-biomarkers-of-idiopathic-pulmonary-fibrosis-at-baseline-an%2F" data-toggle="tooltip" data-placement="top" title="Facebook" target="_blank" rel="noopener" aria-label="Facebook"> <i class="fa-fw fab fa-facebook-square"></i> </a> <a href="https://t.me/share/url?url=https%3A%2F%2Fclinicaltree.github.io%2Fposts%2Fcomparison-of-the-quantitative-ct-imaging-biomarkers-of-idiopathic-pulmonary-fibrosis-at-baseline-an%2F&text=Comparison%20of%20the%20Quantitative%20CT%20Imaging%20Biomarkers%20of%20Idiopathic%20Pulmonary%20Fibrosis%20at%20Baseline%20and%20Early%20Change%20with%20an%20Interval%20of%207%20Months%20-%20Radiology%20Tree" data-toggle="tooltip" data-placement="top" title="Telegram" target="_blank" rel="noopener" aria-label="Telegram"> <i class="fa-fw fab fa-telegram"></i> </a> <i id="copy-link" class="fa-fw fas fa-link small" data-toggle="tooltip" data-placement="top" title="Copy link" data-title-succeed="Link copied successfully!"> </i> </span></div></div></div></div></div><div id="panel-wrapper" class="col-xl-3 pl-2 text-muted"><div class="access"><div id="access-lastmod" class="post"><div class="panel-heading">Recently Updated</div><ul class="post-content pl-0 pb-1 ml-1 mt-2"><li><a href="/posts/neurometabolites-alteration-in-the-acute-phase-of-mild-traumatic-brain-injury-mtbi/">Neurometabolites Alteration in the Acute Phase of Mild Traumatic Brain Injury (mTBI)</a><li><a href="/posts/reinforcing-the-importance-and-feasibility-of-implementing-a-low-dose-protocol-for-ct-guided-biopsie/">Reinforcing the Importance and Feasibility of Implementing a Low-dose Protocol for CT-guided Biopsies</a><li><a href="/posts/rethinking-the-pgy-1-basic-clinical-year/">Rethinking the PGY-1 Basic Clinical Year</a><li><a href="/posts/single-injection-dual-phase-cone-beam-ct-dp-cbct-vascular-anatomy-assessment-and-occult-nodule-det/">Single Injection Dual-Phase Cone Beam CT (DP-CBCT) Vascular Anatomy Assessment and Occult Nodule Detection; Have We Reached the Focus?</a><li><a href="/posts/the-yellow-scale-is-superior-to-the-gray-scale-for-detecting-acute-ischemic-stroke-on-a-monitor-disp/">The Yellow Scale Is Superior to the Gray Scale for Detecting Acute Ischemic Stroke on a Monitor Display in Computed Tomography</a></ul></div><div id="access-tags"><div class="panel-heading">Trending Tags</div><div class="d-flex flex-wrap mt-3 mb-1 mr-3"> <a class="post-tag" href="/tags/general-radiology/">General Radiology</a> <a class="post-tag" href="/tags/journals/">Journals</a></div></div></div><div id="toc-wrapper" class="pl-0 pr-4 mb-5"><div class="panel-heading pl-3 pt-2 mb-2">Contents</div><nav id="toc"></nav></div><script src="https://cdn.jsdelivr.net/npm/tocbot@4.20.1/dist/tocbot.min.js"></script></div></div><div class="row"><div id="tail-wrapper" class="col-12 col-lg-11 col-xl-9 pl-3 pr-3 pr-xl-4 mt-5"><div id="related-posts" class="mb-2 mb-sm-4"><h3 class="pt-2 mb-4 ml-1" data-toc-skip>Further Reading</h3><div class="card-deck mb-4"><div class="card"> <a href="/posts/a-defining-moment/"><div class="card-body"> <em class="small" data-ts="1420045200" data-df="ll" > Dec 31, 2014 </em><h3 class="pt-0 mt-1 mb-3" data-toc-skip>A Defining Moment</h3><div class="text-muted small"><p> “What would be the single most important aspect of radiology that would define our future in the next few decades?”… Asking a potent and powerful question facilitates deep thought, rigorous search,...</p></div></div></a></div><div class="card"> <a href="/posts/abr-core-examination-preparation/"><div class="card-body"> <em class="small" data-ts="1420045200" data-df="ll" > Dec 31, 2014 </em><h3 class="pt-0 mt-1 mb-3" data-toc-skip>ABR Core Examination Preparation</h3><div class="text-muted small"><p> Rationale and Objectives A survey was administered to fourth-year radiology residents after receiving their results from the first American Board of Radiology (ABR) Core examination in 2013. The p...</p></div></div></a></div><div class="card"> <a href="/posts/anxiety-of-patients-undergoing-ct-imaging-an-underestimated-problem/"><div class="card-body"> <em class="small" data-ts="1420045200" data-df="ll" > Dec 31, 2014 </em><h3 class="pt-0 mt-1 mb-3" data-toc-skip>Anxiety of Patients Undergoing CT Imaging—An Underestimated Problem?</h3><div class="text-muted small"><p> Rationale and Objectives Prospective evaluation of anxiety in patients undergoing computed tomography (CT) imaging using a standardized state-trait anxiety inventory (STAI-S) and identification of...</p></div></div></a></div></div></div><div class="post-navigation d-flex justify-content-between"> <a href="/posts/clinical-utility-of-quantitative-imaging/" class="btn btn-outline-primary" prompt="Older"><p>Clinical Utility of Quantitative Imaging</p></a> <a href="/posts/development-of-the-amser-standardized-examinations-in-radiology-for-medical-students/" class="btn btn-outline-primary" prompt="Newer"><p>Development of the AMSER Standardized Examinations in Radiology for Medical Students</p></a></div></div></div></div><div id="search-result-wrapper" class="d-flex justify-content-center unloaded"><div class="col-12 col-sm-11 post-content"><div id="search-hints"><div id="access-tags"><div class="panel-heading">Trending Tags</div><div class="d-flex flex-wrap mt-3 mb-1 mr-3"> <a class="post-tag" href="/tags/general-radiology/">General Radiology</a> <a class="post-tag" href="/tags/journals/">Journals</a></div></div></div><div id="search-results" class="d-flex flex-wrap justify-content-center text-muted mt-3"></div></div></div></div><footer><div class="container pl-lg-4 pr-lg-4"><div class="d-flex justify-content-between align-items-center text-muted ml-md-3 mr-md-3"><div class="footer-left"><p class="mb-0"> © 2023 <a href="https://twitter.com/username">Clinical Team</a>. <span data-toggle="tooltip" data-placement="top" title="Except where otherwise noted, the blog posts on this site are licensed under the Creative Commons Attribution 4.0 International (CC BY 4.0) License by the author.">Some rights reserved.</span></p></div><div class="footer-right"><p class="mb-0">Using the <a href="https://jekyllrb.com" target="_blank" rel="noopener">Jekyll</a> theme <a href="https://github.com/cotes2020/jekyll-theme-chirpy" target="_blank" rel="noopener">Chirpy</a>.</p></div></div></div></footer><div id="mask"></div><a id="back-to-top" href="#" aria-label="back-to-top" class="btn btn-lg btn-box-shadow" role="button"> <i class="fas fa-angle-up"></i> </a><div id="notification" class="toast" role="alert" aria-live="assertive" aria-atomic="true" data-animation="true" data-autohide="false"><div class="toast-header"> <button type="button" class="ml-2 ml-auto close" data-dismiss="toast" aria-label="Close"> <span aria-hidden="true">&times;</span> </button></div><div class="toast-body text-center pt-0"><p class="pl-2 pr-2 mb-3">A new version of content is available.</p><button type="button" class="btn btn-primary" aria-label="Update"> Update </button></div></div><script src="https://cdn.jsdelivr.net/npm/simple-jekyll-search@1.10.0/dest/simple-jekyll-search.min.js"></script> <script> SimpleJekyllSearch({ searchInput: document.getElementById('search-input'), resultsContainer: document.getElementById('search-results'), json: '/assets/js/data/search.json', searchResultTemplate: '<div class="pl-1 pr-1 pl-sm-2 pr-sm-2 pl-lg-4 pr-lg-4 pl-xl-0 pr-xl-0"> <a href="{url}">{title}</a><div class="post-meta d-flex flex-column flex-sm-row text-muted mt-1 mb-1"> {categories} {tags}</div><p>{snippet}</p></div>', noResultsText: '<p class="mt-5">Oops! No results found.</p>', templateMiddleware: function(prop, value, template) { if (prop === 'categories') { if (value === '') { return `${value}`; } else { return `<div class="mr-sm-4"><i class="far fa-folder fa-fw"></i>${value}</div>`; } } if (prop === 'tags') { if (value === '') { return `${value}`; } else { return `<div><i class="fa fa-tag fa-fw"></i>${value}</div>`; } } } }); </script> <script src="https://cdn.jsdelivr.net/combine/npm/magnific-popup@1.1.0/dist/jquery.magnific-popup.min.js,npm/lazysizes@5.3.2/lazysizes.min.js,npm/clipboard@2.0.11/dist/clipboard.min.js"></script> <script src="https://cdn.jsdelivr.net/combine/npm/dayjs@1.11.6/dayjs.min.js,npm/dayjs@1.11.6/locale/en.min.js,npm/dayjs@1.11.6/plugin/relativeTime.min.js,npm/dayjs@1.11.6/plugin/localizedFormat.min.js"></script> <script defer src="/assets/js/dist/post.min.js"></script> <script src="https://cdn.jsdelivr.net/npm/bootstrap@4.6.2/dist/js/bootstrap.bundle.min.js"></script> <script defer src="/app.js"></script> <script defer src="https://www.googletagmanager.com/gtag/js?id=G-L66SLQK23K"></script> <script> document.addEventListener("DOMContentLoaded", function(event) { window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-L66SLQK23K'); }); </script>
